You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Porcupine inhibitor

Showing 1 - 25 of 7,356
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Subjects Trial in Glendale (Nintedanib, AZD5055)

Not yet recruiting
  • Healthy Subjects
  • Glendale, United Kingdom
    Research Site
Dec 1, 2022

Idiopathic Pulmonary Fibrosis Trial in Brooklyn (AZD5055, Placebo)

Recruiting
  • Idiopathic Pulmonary Fibrosis
  • Brooklyn, Maryland
    Research Site
Dec 22, 2022

Peripheral T Cell Lymphoma Trial in Beijing (Linperlisib in combined with Chidamide)

Recruiting
  • Peripheral T Cell Lymphoma
  • Linperlisib in combined with Chidamide
  • Beijing, Beijing/China, China
  • +1 more
Oct 9, 2023

Cutaneous T-cell Lymphoma Trial in Beijing (Linperlisib in combined with Chidamide)

Recruiting
  • Cutaneous T-cell Lymphoma
  • Linperlisib in combined with Chidamide
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Sep 8, 2023

Cervical Cancer Trial in Amsterdam (Anti-PD-1 antibody balstilimab)

Not yet recruiting
  • Cervical Cancer
  • Anti-PD-1 antibody balstilimab
  • Amsterdam, Netherlands
    Amsterdam UMC
Oct 17, 2023

Hepatocellular Carcinoma (HCC) Trial in Taiwan (Chidamide, Regorafenib)

Recruiting
  • Hepatocellular Carcinoma (HCC)
  • Kaohsiung, Taiwan
  • +4 more
Mar 14, 2023

HIV Trial in Las Vegas, Austin (VH4004280, Placebo)

Not yet recruiting
  • HIV Infections
  • Las Vegas, Nevada
  • +1 more
Aug 21, 2023

Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer Trial (OP-1250, Fulvestrant, Anastrozole)

Not yet recruiting
  • Breast Cancer
  • +4 more
  • (no location specified)
Aug 31, 2023

Differentiated Thyroid Cancer Trial in Pavia (Pembrolizumab)

Not yet recruiting
  • Differentiated Thyroid Cancer
  • Pavia, Lombardia, Italy
    Istituti Clinici Scientifici Maugeri
May 5, 2023

Blood Vessel Function in Postmenopausal Women With Breast Cancer

Active, not recruiting
  • Breast Cancer
  • Rochester, Minnesota
    Mayo Clinic
Jan 17, 2023

Chronic Kidney Disease Trial (Part A - Lorundrostat QD + Dapaglifozin QD, Part A - Lorundrostat QD, Part B - Lorundrostat QD

Not yet recruiting
  • Chronic Kidney Disease
  • Part A - Lorundrostat QD + Dapaglifozin QD
  • +2 more
  • (no location specified)
Nov 27, 2023

Advanced Pancreatic Adenocarcinoma, Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma Trial in Boston (Zentalis, Gemzar)

Not yet recruiting
  • Advanced Pancreatic Adenocarcinoma
  • +2 more
  • Boston, Massachusetts
  • +1 more
Aug 23, 2023

Adenoid Cystic Carcinoma, Metastatic Adenoid Cystic Carcinoma, Recurrent Adenoid Cystic Carcinoma Trial in Boston (CB-103,

Not yet recruiting
  • Adenoid Cystic Carcinoma
  • +2 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Mar 14, 2023

Healthy Trial in Biberach (BI 1810631, Itraconazole)

Recruiting
  • Healthy
  • Biberach, Germany
    Humanpharmakologisches Zentrum Biberach
Apr 27, 2023

Vonoprazan, Helicobacter Pylori Infection, Proton Pump Inhibitor Trial in Hangzhou (Tegoprazan, Esomeprazole)

Active, not recruiting
  • Vonoprazan
  • +2 more
  • Hangzhou, Zhejiang, China
    Hangzhou first people's Hospital
Dec 2, 2022

Acute Myeloid Leukemia (AML) Trial in Birmingham, San Francisco, New York (ZN-d5 ZN-c3, ZN-c3)

Recruiting
  • Acute Myeloid Leukemia (AML)
  • Birmingham, Alabama
  • +2 more
Jan 3, 2023

Atypical Hemolytic Uremic Syndrome (aHUS) Trial in Worldwide (Ravulizumab)

Active, not recruiting
Has Results
  • Atypical Hemolytic Uremic Syndrome (aHUS)
  • Ravulizumab
  • Aurora, Colorado
  • +19 more
Nov 16, 2022

Vonoprazan, Helicobacter Pylori Infection, Proton Pump Inhibitor Trial in Hangzhou (Vonoprazan Tablets, Amoxicillin Capsules,

Recruiting
  • Vonoprazan
  • +2 more
  • Vonoprazan Tablets
  • +2 more
  • Hangzhou, Zhejiang, China
    Hangzhou first people's Hospital
Nov 23, 2022

Her-2 Negative Breast Cancer, HRR Gene Mutation Trial in Guangzhou (Camrelizumab, Fluzoparib, Nab-paclitaxel)

Recruiting
  • Her-2 Negative Breast Cancer
  • HRR Gene Mutation
  • Guangzhou, Guangdong, China
    First Affiliated Hospital, Sun Yat-Sen University
Mar 7, 2023

Examining the Effect of Endocrine Therapy on Aging

Recruiting
  • Breast Neoplasm Female
  • +2 more
  • Aromatase inhibitor
  • Ann Arbor, Michigan
    University of Michigan Rogel Cancer Center
Jan 17, 2023

Breast Cancer Trial in Wuhan (Adebrelimab, dalpiciclib)

Recruiting
  • Breast Cancer
  • Wuhan, Hubei, China
    Tongji Hospital Affiliated of Tongji Medical College Huazhong Un
Nov 20, 2023

Metastatic Breast Cancer Trial in Seoul (Fulvestrant plus AI plus ribociclib, AI plus ribociclib)

Not yet recruiting
  • Metastatic Breast Cancer
  • Fulvestrant plus AI plus ribociclib
  • AI plus ribociclib
  • Seoul, Korea, Republic of
    Korea university Guro hospital
Apr 16, 2023

Healthy Male Trial in Shanghai (D-1553)

Active, not recruiting
  • Healthy Male
  • Shanghai, Shanghai, China
    Shanghai Xuhui District Central Hospital
Oct 23, 2023

Diabetes, Cellular Senescence, Sodium-Glucose Transporter 2 Inhibitors Trial in Seoul (SGLT2 inhibitor, Glimepiride)

Not yet recruiting
  • Diabetes Mellitus
  • +2 more
  • Seoul, Korea, Republic of
    Yonsei University College of Medicine
Aug 1, 2023

Relapsed/ Refractory Multiple Myeloma Trial in Worldwide (Talquetamab, Teclistamab, PD-1 Inhibitor)

Recruiting
  • Relapsed/ Refractory Multiple Myeloma
  • Denver, Colorado
  • +19 more
Jan 27, 2023